10 / 26 / 2022
Check out – It’s our favorite image of the PINK October!
More than a color, more than a month…
🎗Our everyday challenge by supporting cancer research, with a pink hope to win this fight!🎗
10 / 20 / 2022
We very much look forward to attending the @Society for Immunotherapy of Cancer Annual Meeting in Boston from November 8 to 12, and to showcasing our recent research works through our posters. Plan to stop by to talk of them and about your research programs.
Interested in meeting us to learn on our services offerings and how they can support your needs? Reach us for scheduling!
09 / 08 / 2022
Save the date for our new in vivo shuttle campaign!
We are committed to providing world-class supports to advance your preclinical projects and immunotherapy drug discovery using syngeneic tumor mouse models through our comprehensive in vivo Immuno-Oncology platform.
Sign up! It’s for early November
07 / 12 / 2022
Check out - it's our favorite image of the month
What a pretty multiplexed image showing the tumor microenvironment (TME) on a human NSCLC section, highlighting PDL1 positive tumor cells surrounded by macrophages and T cells.
07 / 07 / 2022
Discover our main news for the first half of 2022!
Hear about the great opportunity that is our partnership with Domain Therapeutics, new cutting-edge platforms for biomarker translational research as well as our newest featured publication!
06 / 16 / 2022
Check out - it's our favorite image of the month
Summer beginning, look at a real fireworks 🎆! Human cerebral cortex nerve cells lit up on section!
05 / 19 / 2022
From June 3 to 7, 2022, we will be setting up our quarters in Chicago for the American Society of Clinical Oncology Annual Meeting to continue gaining the latest insights in research and clinical development in Oncology. Also, our CEO Dr. Alban Bessede will have the great opportunity to present a scientific poster highlighting our recent advances in biomarker research in Immuno-Oncology.
05 / 04 / 2022
In the era of immuno-oncology, it’s critical to unravel mechanisms of action underlying sensitivity or resistance to current immunotherapies in order to identify predictive biomarkers of response and then discover novel actionable therapeutic targets.
04 / 21 / 2022
Back from the AACR 2022, it was a pleasure to take part in it and to converse about our posters showcasing our newest preclinical and translational research advances in Immuno-Oncology.
If you didn't get the chance to meet us and see our posters, or if you want to review them, you can directly download them from the form below.
03 / 29 / 2022
We will be attending the AACR Annual Meeting in New Orleans, from April 8 to 13, 2022. We will be glad to take this opportunity to meet you there, approach your research projects and introduce our service offerings. We will also presentsome scientific posters to highlight our latest innovative preclinical and translational research advances.